Johan Pluvy
Aix-Marseille Université(FR)Assistance Publique Hôpitaux de Marseille(FR)Hôpital Nord(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Research Studies
Most-Cited Works
- → Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer(2019)170 cited
- → Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study(2019)104 cited
- → Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment(2017)29 cited
- → Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study(2020)20 cited
- → Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors(2020)17 cited
- → Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors(2020)14 cited